HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Judith E Karp Selected Research
Judith E Karp Research Topics
Disease
59
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 07/2002
35
Neoplasms (Cancer)
01/2019 - 07/2002
34
Leukemia
11/2021 - 07/2002
13
Hematologic Neoplasms (Hematological Malignancy)
11/2017 - 08/2002
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2021 - 07/2002
5
Myeloid Leukemia (Leukemia, Myelocytic)
01/2019 - 07/2002
5
Mucositis
01/2019 - 06/2005
5
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2008 - 07/2002
4
Lymphoma (Lymphomas)
11/2018 - 01/2012
4
Breast Neoplasms (Breast Cancer)
01/2016 - 08/2003
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2015 - 08/2003
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2014 - 12/2003
3
Myeloproliferative Disorders (Myeloproliferative Disorder)
09/2008 - 04/2003
2
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2017 - 04/2003
2
Stomatitis
02/2015 - 03/2005
2
Pathologic Complete Response
11/2012 - 05/2008
2
Ataxia Telangiectasia (Louis Bar Syndrome)
10/2012 - 07/2005
2
Acute Promyelocytic Leukemia
01/2011 - 06/2005
1
Hematologic Diseases (Blood Diseases)
01/2023
1
Hypoalbuminemia
12/2021
1
Acute Disease
11/2021
1
Philadelphia Chromosome
11/2021
1
Acute Biphenotypic Leukemia (Leukemia, Mixed Cell)
11/2021
1
Body Weight (Weight, Body)
01/2019
1
Fanconi Anemia (Fanconi's Anemia)
02/2017
1
Hypersensitivity (Allergy)
01/2016
1
Genetic Translocation (Chromosomal Translocation)
01/2015
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015
1
Disease Progression
01/2015
Drug/Important Bio-Agent (IBA)
21
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2018 - 04/2003
13
alvocidib (flavopiridol)
IBA
01/2018 - 01/2003
10
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2018 - 06/2004
10
tipifarnib (R115777)
IBA
01/2014 - 07/2002
8
Farnesyltranstransferase (Farnesyltransferase)
IBA
01/2014 - 07/2002
8
Proteins (Proteins, Gene)
FDA Link
11/2011 - 09/2002
7
veliparib
IBA
01/2019 - 05/2010
6
Phosphotransferases (Kinase)
IBA
01/2016 - 07/2004
5
Histone Deacetylase Inhibitors
IBA
11/2021 - 01/2005
5
Topotecan (Hycamtin)
FDA Link
Generic
11/2017 - 06/2004
5
Poly(ADP-ribose) Polymerase Inhibitors
IBA
02/2017 - 03/2014
4
entinostat (MS 275)
IBA
11/2021 - 01/2005
4
Carboplatin (JM8)
FDA Link
Generic
11/2017 - 09/2005
4
MK-8776
IBA
10/2017 - 10/2012
4
Enzymes
IBA
07/2017 - 09/2003
4
Etoposide (VP 16)
FDA Link
Generic
01/2012 - 04/2003
4
Transferases
IBA
11/2005 - 09/2003
3
Biomarkers (Surrogate Marker)
IBA
12/2021 - 01/2014
3
Ligands
IBA
01/2021 - 10/2007
3
DNA (Deoxyribonucleic Acid)
IBA
02/2015 - 06/2006
3
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
04/2014 - 09/2007
3
3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)
IBA
04/2014 - 09/2007
3
Checkpoint Kinase 1
IBA
10/2012 - 07/2005
3
Idarubicin (4 Demethoxydaunorubicin)
FDA Link
Generic
10/2009 - 04/2003
3
Mitogen-Activated Protein Kinases
IBA
07/2005 - 09/2003
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2004 - 04/2003
2
Clofarabine (Clolar)
FDA Link
11/2021 - 09/2007
2
midostaurin
IBA
01/2020 - 11/2006
2
Temozolomide (Temodar)
FDA Link
Generic
01/2019 - 02/2017
2
Daunorubicin (Cerubidine)
FDA Link
Generic
01/2018 - 09/2015
2
TOR Serine-Threonine Kinases
IBA
01/2016 - 01/2012
2
Sorafenib (BAY 43-9006)
FDA Link
09/2014 - 10/2007
2
fludarabine
IBA
04/2014 - 01/2008
2
Imatinib Mesylate (Gleevec)
FDA Link
06/2012 - 09/2008
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
11/2011 - 07/2005
2
tanespimycin (17AAG)
IBA
11/2011 - 07/2005
2
17-aminogeldanamycin
IBA
11/2011 - 07/2005
2
Methyltransferases
IBA
01/2011 - 06/2006
2
beta Catenin
IBA
09/2010 - 08/2002
2
Anthracyclines
IBA
04/2010 - 09/2009
2
Immunomodulating Agents
IBA
09/2008 - 12/2005
2
Nucleosides
IBA
01/2008 - 07/2005
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
07/2004 - 08/2003
2
Semaxinib (SU5416)
IBA
07/2004 - 08/2003
1
Albumins
IBA
12/2021
1
Serum Albumin
IBA
12/2021
1
ivosidenib
IBA
01/2020
1
Gemtuzumab (Mylotarg)
FDA Link
01/2020
1
venetoclax
IBA
01/2020
1
glasdegib
IBA
01/2020
1
Creatinine
IBA
01/2019
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
07/2017
1
Histones (Histone)
IBA
02/2017
1
Poly (ADP-Ribose) Polymerase-1
IBA
02/2017
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
02/2015
1
vosaroxin
IBA
02/2015
1
Quinolones
IBA
02/2015
1
Immunoglobulins (Immunoglobulin)
IBA
01/2015
1
Cytidine Deaminase
IBA
01/2015
1
Death Domain Receptors
IBA
07/2014
Therapy/Procedure
28
Therapeutics
01/2023 - 07/2002
9
Drug Therapy (Chemotherapy)
10/2023 - 06/2004
2
Transplantation
11/2018 - 04/2012
2
Precision Medicine
01/2016 - 12/2014
2
Induction Chemotherapy
04/2015 - 06/2014
2
Homologous Transplantation
11/2012 - 09/2011
1
Immunotherapy
11/2021
1
Hematopoietic Stem Cell Transplantation
01/2021
1
FLAM regimen
07/2017
1
Combination Drug Therapy (Combination Chemotherapy)
12/2015
1
Adjuvant Chemotherapy
02/2015